Erdafitinib for locally advanced or metastatic urothelial carcinoma
Siefker-Radtke, Arlene O, Loriot, Yohann
openaire +2 more sources
ABSTRACT Introduction Peritoneal carcinomatosis in patients with advanced bladder cancer is a rare but lethal event following robot‐assisted radical cystectomy (RARC). We report a case of an unusual clinical course in which peritoneal dissemination of colon cancer was unexpectedly detected seven months after RARC.
Kana Ito +8 more
wiley +1 more source
Real-world use of enfortumab vedotin in metastatic urothelial carcinoma: efficacy, safety, and risk stratification. [PDF]
Catalano M +13 more
europepmc +1 more source
ABSTRACT Introduction Bladder cancer (BC) is rarely associated with common bile duct (CBD) obstruction. We report a case of BC with peritoneal invasion and rectal involvement complicated by bilateral ureteral and biliary obstruction. Case Presentation A 77‐year‐old man presented with abdominal pain.
Kazuto Imai +6 more
wiley +1 more source
Metastatic urothelial carcinoma of the urethra and glans penis with reported implantation via the urine: A case report. [PDF]
Kalinowski P +6 more
europepmc +1 more source
Gene signature for response prediction to immunotherapy and prognostic markers in metastatic urothelial carcinoma. [PDF]
Langfelder P +4 more
europepmc +1 more source
ABSTRACT Introduction Extraperitoneal tubeless umbilical cutaneous ureterostomy is a useful urinary diversion technique for patients with shortened ureters or high risk of upper urinary tract recurrence. However, radical nephroureterectomy following this diversion has not been previously reported.
Tsubasa Kondo +4 more
wiley +1 more source
A retroperitoneal urinoma secondary to metastatic urothelial carcinoma mimicking psoas muscle malignancy: Case Report and literature review. [PDF]
Li T, Lv H.
europepmc +1 more source
Microbiome‐urothelium crosstalk in bladder cancer: From dysbiosis to clinical translation
This review elucidates the critical crosstalk between the urobiome and bladder cancer (BCa), mapping the landscape from ecological dysbiosis to clinical translation. We synthesize emerging evidence on microbial signatures that distinguish BCa patients, exploring key carcinogenic mechanisms including chronic inflammation, genotoxicity, and the gut ...
Haoxiang Xu +14 more
wiley +1 more source
Long-Term Control after Intermittent Reintroduction of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Case Report. [PDF]
Fujii K +9 more
europepmc +1 more source

